Legal Representation
Attorney
Jacqueline M. Lesser
USPTO Deadlines
Next Deadline
69 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 16, 2026
Extension Available
Until July 16, 2025
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 15, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 15, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 15, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 15, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 16, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 21, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Oct 31, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 31, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 31, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 17, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 16, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 16, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 27, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business consulting and management in the fields of automated integration, centralized process control and data access for clinical trials; Business consulting services in the fields of automated integration, centralized process control and data access, namely support of centralized data access, process control and document submission management for clinical data and regulatory submission management, namely, assisting others with audit, document presentation and regulatory compliance for clinical and commercial manufacturing for submission to regulatory authorities on behalf of medical, biopharmaceutical and biotechnology companies
Class 042
Providing online, nondownloadable software for use in automated integration, centralized process control and data access for clinical trials; Providing online, nondownloadable software for use in automated integration, centralized process control and data access for regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies
Class 045
Advice and consultancy on health regulatory matters, medical device regulatory matters and pharmaceutical regulatory matters; regulatory compliance consulting in the field of regulatory compliance for healthcare, medical devices and pharmaceuticals; tracking and monitoring regulatory requirements in the field of manufacturing for healthcare, medical devices and pharmaceutical industries for regulatory compliance purposes
Additional Information
Design Mark
The mark consists of an upside down bolded "V" with a shaded block on the left leg of the "V" in front of the bolded word "AGILE" in capital letters followed with a space and then bolded capital "G", shaded lowercase "X", followed by a bolded capital "P".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
035
042
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"AGILE GXP"